Showing results (161-170 of 267) with videos related to
Sort By:
Pageof 27
Transfusion Medicine Reviews|March 26, 2018
Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante de Medula Osea en Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH)Marta González-Vicent, Jaime Sanz, José Luis Fuster, et al.Plos One|June 9, 2022
Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly populationLidia Cobos-Palacios, María Isabel Ruiz-Moreno, Alberto Vilches-Perez, et al.Mycoses|January 12, 2019
Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipientsRebeca Rodríguez-Veiga, Pau Montesinos, Estefanía García, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantationCelso A Rodrigues, Guillermo Sanz, Claudio G Brunstein, et al.Journal of Hematology & Oncology|May 29, 2023
Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Didier Blaise, et al.Revista Iberoamericana De Micologia|April 11, 2015
Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairmentPau Montesinos, Rebeca Rodríguez-Veiga, David Martínez-Cuadrón, et al.Annals of Hematology|April 29, 2017
Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicinRebeca Rodríguez-Veiga, Begoña Igual, Pau Montesinos, et al.Blood Neoplasia|April 6, 2026
Late outcomes after posttransplant cyclophosphamide-based GVHD prophylaxis in patients with AML: an ALWP-EBMT studyEduardo Rodríguez-Arbolí, Allain-Thibeault Ferhat, Anna Maria Raiola, et al.Bone Marrow Transplantation|December 24, 2025
The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutationsIman Abou Dalle, Jacques-Emmanuel Galimard, Xavier Poire, et al.International Journal of Dermatology|December 10, 2025
Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell TransplantationMiguel Mansilla-Polo, Juan Montoro, Javier López-Davia, et al.Pageof 27